Clinical trial
Fingolimod for Type 2 Diabetes Mellitus: a Pilot, Prospective, Randomized, and Open Label Single-center Study
NCT05307731 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fingolimod for Type 2 Diabetes Mellitus: a Pilot, Prospective, Randomized, and Open Label Single-center Study
- Lead sponsor
- General Hospital of Shenyang Military Region
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 15, 2022
- Completion date
- March 15, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.